Tony Michael Argenbright

Array ( [id] => 5667591 [patent_doc_number] => 20060172941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Anti-angiogenic peptides and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/327849 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15556 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172941.pdf [firstpage_image] =>[orig_patent_app_number] => 11327849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875191 [patent_doc_number] => 20060166889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'INSULIN CONJUGATES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/327647 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14292 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166889.pdf [firstpage_image] =>[orig_patent_app_number] => 11327647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694719 [patent_doc_number] => 20060154866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level' [patent_app_type] => utility [patent_app_number] => 11/328405 [patent_app_country] => US [patent_app_date] => 2006-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 77193 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154866.pdf [firstpage_image] =>[orig_patent_app_number] => 11328405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875891 [patent_doc_number] => 20060167220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Methods and compositions for preparing peptides with excellent solubility characteristics in aqueous solution at physiological pH' [patent_app_type] => utility [patent_app_number] => 11/321035 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15650 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167220.pdf [firstpage_image] =>[orig_patent_app_number] => 11321035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92492 [patent_doc_number] => 07737251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders' [patent_app_type] => utility [patent_app_number] => 11/318323 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 14508 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737251.pdf [firstpage_image] =>[orig_patent_app_number] => 11318323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826988 [patent_doc_number] => 07402654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'PHI 15 DNA polymerase' [patent_app_type] => utility [patent_app_number] => 11/315390 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 4384 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402654.pdf [firstpage_image] =>[orig_patent_app_number] => 11315390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596803 [patent_doc_number] => 20060160721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Method of plasma lipidation to prevent, inhibit and/or reverse atherosclerosis' [patent_app_type] => utility [patent_app_number] => 11/316062 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23194 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160721.pdf [firstpage_image] =>[orig_patent_app_number] => 11316062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865523 [patent_doc_number] => 20060099653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Microscopic precision construction of tissue array block related application data' [patent_app_type] => utility [patent_app_number] => 11/302633 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8084 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099653.pdf [firstpage_image] =>[orig_patent_app_number] => 11302633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 523379 [patent_doc_number] => 07186798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-06 [patent_title] => 'Fluorescently labeled growth hormone secretagogue' [patent_app_type] => utility [patent_app_number] => 11/299533 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4698 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186798.pdf [firstpage_image] =>[orig_patent_app_number] => 11299533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844335 [patent_doc_number] => 20060122122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Antimicrobial peptides and use thereof' [patent_app_type] => utility [patent_app_number] => 11/294583 [patent_app_country] => US [patent_app_date] => 2005-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11635 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122122.pdf [firstpage_image] =>[orig_patent_app_number] => 11294583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595736 [patent_doc_number] => 20060159652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Gd2 ligands' [patent_app_type] => utility [patent_app_number] => 10/528542 [patent_app_country] => US [patent_app_date] => 2003-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10714 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159652.pdf [firstpage_image] =>[orig_patent_app_number] => 10528542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5610534 [patent_doc_number] => 20060272050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Polypeptides having antimicrobial activity and polynucleotides encoding same' [patent_app_type] => utility [patent_app_number] => 11/282519 [patent_app_country] => US [patent_app_date] => 2005-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22694 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20060272050.pdf [firstpage_image] =>[orig_patent_app_number] => 11282519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705677 [patent_doc_number] => 20060194725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Methods of treating disease with random copolymers' [patent_app_type] => utility [patent_app_number] => 11/283405 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 30095 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194725.pdf [firstpage_image] =>[orig_patent_app_number] => 11283405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82194 [patent_doc_number] => 07745577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Compounds that bind to P185 and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/283474 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 20951 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745577.pdf [firstpage_image] =>[orig_patent_app_number] => 11283474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924967 [patent_doc_number] => 20060241281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Peptidomimetic polymers for antifouling surfaces' [patent_app_type] => utility [patent_app_number] => 11/280107 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4471 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241281.pdf [firstpage_image] =>[orig_patent_app_number] => 11280107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 536484 [patent_doc_number] => 07173110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Peptide anti-tumor agent' [patent_app_type] => utility [patent_app_number] => 11/264684 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8598 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173110.pdf [firstpage_image] =>[orig_patent_app_number] => 11264684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694715 [patent_doc_number] => 20060154862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Processes for preparing a polypeptide' [patent_app_type] => utility [patent_app_number] => 11/262122 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11998 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154862.pdf [firstpage_image] =>[orig_patent_app_number] => 11262122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515381 [patent_doc_number] => 07932229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Compositions and methods for the control of mammary cell number' [patent_app_type] => utility [patent_app_number] => 11/666143 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8279 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932229.pdf [firstpage_image] =>[orig_patent_app_number] => 11666143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582661 [patent_doc_number] => 07449445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Conductive peptide nanofiber and method of manufacture of the same' [patent_app_type] => utility [patent_app_number] => 11/252719 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 26 [patent_no_of_words] => 7530 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449445.pdf [firstpage_image] =>[orig_patent_app_number] => 11252719 [rel_patent_id] =>[rel_patent_doc_number] =>)